139 related articles for article (PubMed ID: 3871182)
1. HLA-B8/DR3 phenotype and the primary immune response.
Kallenberg CG; Klaassen RJ; Beelen JM; The TH
Clin Immunol Immunopathol; 1985 Jan; 34(1):135-40. PubMed ID: 3871182
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin genes, HLA-B8/DR3, and immune responsiveness to primary immunogen and mitogens in normal subjects.
Kallenberg CG; Klaassen RJ; Westra J; Beelen JM; Ockhuizen T
Clin Immunol Immunopathol; 1988 Jun; 47(3):333-42. PubMed ID: 3259481
[TBL] [Abstract][Full Text] [Related]
3. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
Modica MA; Cammarata G; Caruso C
J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
[TBL] [Abstract][Full Text] [Related]
4. Elevated natural killer cytotoxicity in HLA-B8 and HLA-DR3-positive individuals.
Jakobisiak M; Saidman S; Schlaut J; Pazderka F; Dossetor JB
Immunol Lett; 1986 Mar; 12(2-3):61-3. PubMed ID: 3087867
[TBL] [Abstract][Full Text] [Related]
5. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
Amer A; Singh G; Darke C; Dolby AE
Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
[TBL] [Abstract][Full Text] [Related]
6. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.
Kallenberg CG; Van der Voort-Beelen JM; D'Amaro J; The TH
Clin Exp Immunol; 1981 Mar; 43(3):478-85. PubMed ID: 6945162
[TBL] [Abstract][Full Text] [Related]
7. Histologic findings in siblings with acute sarcoid arthritis: association with the B8,DR3 phenotype.
Kremer JM
J Rheumatol; 1986 Jun; 13(3):593-7. PubMed ID: 3488404
[TBL] [Abstract][Full Text] [Related]
8. Increased interleukin-2 receptor affinity in normal HLA A1 B8 DR3 subjects.
Pomier G; Vindimian M; Healy JC; Le Petit JC
J Immunogenet; 1990 Dec; 17(6):371-7. PubMed ID: 2096181
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.
Hashimoto S; McCombs CC; Michalski JP
Clin Exp Immunol; 1989 Jun; 76(3):317-23. PubMed ID: 2787712
[TBL] [Abstract][Full Text] [Related]
10. Linkage disequilibrium of HLA-SB1 with the HLA-A1, B8, DR3, SCO1 and of HLA-SB4 with the HLA-A26, Bw38, Dw10, DR4, SC21 extended haplotypes.
Matsui Y; Alosco SM; Awdeh Z; Duquesnoy RJ; Page PL; Hartzman RJ; Alper CA; Yunis EJ
Immunogenetics; 1984; 20(6):623-31. PubMed ID: 6239824
[TBL] [Abstract][Full Text] [Related]
11. HLA-B8,DR3 T cell impairment is completely restored by in vitro treatment with interleukin-2.
Candore G; Colucci AT; Modica MA; Caruso C
Immunopharmacol Immunotoxicol; 1991; 13(4):551-61. PubMed ID: 1774436
[TBL] [Abstract][Full Text] [Related]
12. Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes.
Porges A; Bussel J; Kimberly R; Schulman I; Pollack M; Pandey J; Barandun S; Hilgartner M
Tissue Antigens; 1985 Aug; 26(2):132-7. PubMed ID: 3877351
[TBL] [Abstract][Full Text] [Related]
13. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
14. HLA-B8,DR3 haplotype affects lymphocyte blood levels.
Caruso C; Bongiardina C; Candore G; Cigna D; Romano GC; Colucci AT; Di Lorenzo G; Gervasi F; Manno M; Potestio M; Tantillo G
Immunol Invest; 1997 Apr; 26(3):333-40. PubMed ID: 9129986
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytokine production by HLA-B8,DR3 positive subjects.
Candore G; Cigna D; Gervasi F; Colucci AT; Modica MA; Caruso C
Autoimmunity; 1994; 18(2):121-32. PubMed ID: 7742473
[TBL] [Abstract][Full Text] [Related]
16. T-cell activation in HLA-B8, DR3-positive individuals. Early antigen expression defect in vitro.
Candore G; Cigna D; Todaro M; De Maria R; Stassi G; Giordano C; Caruso C
Hum Immunol; 1995 Apr; 42(4):289-94. PubMed ID: 7558912
[TBL] [Abstract][Full Text] [Related]
17. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression.
Collier PM; Wojnarowska F; Welsh K; McGuire W; Black MM
Br J Dermatol; 1999 Nov; 141(5):867-75. PubMed ID: 10583169
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte abnormality associated with HLA-B8 in healthy young adults.
McCombs CC; Michalski JP
J Exp Med; 1982 Sep; 156(3):936-41. PubMed ID: 6980966
[TBL] [Abstract][Full Text] [Related]
19. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
[TBL] [Abstract][Full Text] [Related]
20. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
